Clinical Trial Update: Bococizumab HIV Evaluation (B-HIVE) Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for bococizumab (B-HIVE) evaluating HIV-related dyslipidemia and cardiovascular disease; study terminated with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Dyslipidemia

Drugs mentioned

• Bococizumab (bococizumab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Dyslipidemia, Cardiovascular Disease | Phase 3 | Status: TERMINATED | Results posted: 2019-06-19